Approval for the xmi catheter, a modification of the lf140 catheter.  The device as modified, will be marketed under the trade name possis angiojet xmi rheolytic thrombectomy system, and is indicated for removing thrombus in the treatment of patients with symptomatic coronary artery or saphenous vein graft lesions in vessels >=2.0 mm in diameter prior to balloon angioplasty or stent placement.